Who We Are

Ensemble Orthopedics Inc., an Austin, Texas based company, was established in 2019 to develop minimally-invasive and minimally-disruptive, interpositional surgical solutions for the upper extremity arthroplasty market. Our first device, the Ensemble CMC™, received FDA clearance in December 2020.

Our ensemble includes: design pioneers, R&D specialists, biomaterials experts, seasoned sales executives, as well as leaders with experience in business development, regulatory affairs, clinical studies, surgeon education, and the marketing and commercialization of medical devices.

Company Co-Founders

William F. Ogilvie, President & CEO

  • 20 years’ experience developing implants for upper extremities
  • Designed multiple pyrocarbon extremity implants with Ascension Orthopedics
  • Awarded 15 medical device patents

Alastair Clemow, Ph.D., Chairman

  • 35 years’ experience in R&D, business development, and executive management
  • Served on boards including Aevi Genomics, Encore Medical, and BioMedical Enterprises
  • Acted as President of the Society for Biomaterials

Sandie Roth, VP of Operations

  • 15 years’ experience in product development, clinical, quality, and regulatory
  • Managed OUS pre-market clinical studies for US and EU approval
  • Worked for both large orthopedic (Biomet) and start-up (Nexgen Spine) companies

Sonia Champlin, VP of Sales — Account Management

  • 25 years’ experience managing hybrid sales forces and providing clinical support
  • Launched new products at both start-up and established organizations
  • Developed and implemented surgeon/sales education programs